RE: This share22 Jul 2020 09:51
I see no significant downside risk in the next 3 weeks or so. After that it's a different game that will need to be re-assessed, but to me holding for 3 weeks is the best risk reward option. In those 3 weeks a lot of things may/should happen, including TR1s, further trial news, COPD results, potential JV, etc. All of this will edge the price up.
The upside potential is endless - just imagine a bidding war between major pharmas, or, indeed, a government buying us out just for political reasons.
£300m is pocket change. To pharmas, to governments, to major investment houses. Piddly pocket change.